BVT2733 is primarily used in scientific research as a selective activator of the AMP-activated protein kinase (AMPK) pathway. It is employed to study cellular energy regulation, particularly in metabolic diseases such as type 2 diabetes and obesity. Researchers use BVT2733 to investigate glucose uptake in muscle cells, lipid metabolism, and insulin sensitivity in preclinical models. Due to its ability to mimic energy-stress conditions, it also serves as a tool compound in studies related to mitochondrial function and cellular stress responses. Its application remains confined to laboratory and experimental settings, with no current use in clinical medicine.